3 results match your criteria: "Kashi Center for Disease Control and Prevention[Affiliation]"
Emerg Microbes Infect
December 2023
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
China CDC Wkly
June 2021
State Key Laboratory of Virology, School of Health Sciences, Wuhan University, Wuhan, Hubei, China.
Multidrug-resistant tuberculosis (MDR-TB) has become a growing threat to public health. There were few reports about family-to-school MDR-TB outbreaks in China, especially during the coronavirus disease 2019 (COVID-19) pandemic. A tuberculosis (TB) outbreak happened in Hubei Province during the COVID-19 pandemic.
View Article and Find Full Text PDFMed Sci Monit
May 2015
Kashi Center for Disease Control and Prevention, Xinjiang Uygur Autonomous Region, Kashi, Xinjiang, China (mainland).
Background: The prevalence of drug-resistant tuberculosis (TB) in Xinjiang is higher than in other regions of China, and Beijing/W lineage Mycobacterium tuberculosis (MTB) is the dominant strain of MTB in Xinjiang. However, information on multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB, particularly the correlation between MDR and the Beijing/W lineage and the correlation between drug resistance and the Beijing/W sublineage strains, is limited.
Material/methods: We conducted a prospective study to describe the prevalence of MDR/XDR TB, Beijing/W lineage and sublineage strains in Xinjiang in China from 2009 to 2013.